Annual Total Debt
$1.34 M
-$7.84 M-85.42%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual total debt is $1.34 million, with the most recent change of -$7.84 million (-85.42%) on December 31, 2023.
- During the last 3 years, TRVI annual total debt has fallen by -$12.87 million (-90.58%).
- TRVI annual total debt is now -90.85% below its all-time high of $14.63 million, reached on December 31, 2021.
Performance
TRVI Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.11 M
-$80.00 K-6.71%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly total debt is $1.11 million, with the most recent change of -$80.00 thousand (-6.71%) on September 30, 2024.
- Over the past year, TRVI quarterly total debt has dropped by -$225.00 thousand (-16.82%).
- TRVI quarterly total debt is now -92.39% below its all-time high of $14.63 million, reached on December 31, 2021.
Performance
TRVI Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TRVI Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.4% | -16.8% |
| 3 y3 years | -90.6% | -92.3% |
| 5 y5 years | +2808.7% | +194.4% |
TRVI Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | at low | -92.4% | at low |
| 5 y | 5-year | -90.8% | +275.8% | -92.4% | +261.4% |
| alltime | all time | -90.8% | +2808.7% | -92.4% | -100.0% |
Trevi Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.11 M(-6.7%) |
| Jun 2024 | - | $1.19 M(-6.1%) |
| Mar 2024 | - | $1.27 M(-5.0%) |
| Dec 2023 | $1.34 M(-85.4%) | $1.34 M(-4.8%) |
| Sep 2023 | - | $1.41 M(-4.4%) |
| Jun 2023 | - | $1.47 M(-83.7%) |
| Mar 2023 | - | $9.02 M(-1.8%) |
| Dec 2022 | $9.18 M(-37.3%) | $9.18 M(-15.5%) |
| Sep 2022 | - | $10.86 M(-13.3%) |
| Jun 2022 | - | $12.52 M(-11.7%) |
| Mar 2022 | - | $14.18 M(-3.1%) |
| Dec 2021 | $14.63 M | $14.63 M(+0.9%) |
| Sep 2021 | - | $14.50 M(+0.4%) |
| Jun 2021 | - | $14.45 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $14.33 M(+0.8%) |
| Dec 2020 | $14.21 M(+3891.9%) | $14.21 M(+0.9%) |
| Sep 2020 | - | $14.08 M(+4471.8%) |
| Jun 2020 | - | $308.00 K(-7.2%) |
| Mar 2020 | - | $332.00 K(-6.7%) |
| Dec 2019 | $356.00 K(+673.9%) | $356.00 K(-5.8%) |
| Sep 2019 | - | $378.00 K(-5.3%) |
| Jun 2019 | - | $399.00 K(-5.2%) |
| Mar 2019 | - | $421.00 K(+815.2%) |
| Dec 2018 | $46.00 K(-99.1%) | $46.00 K(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00 |
| Dec 2017 | $5.29 M | - |
FAQ
- What is Trevi Therapeutics annual total debt?
- What is the all time high annual total debt for Trevi Therapeutics?
- What is Trevi Therapeutics annual total debt year-on-year change?
- What is Trevi Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly total debt year-on-year change?
What is Trevi Therapeutics annual total debt?
The current annual total debt of TRVI is $1.34 M
What is the all time high annual total debt for Trevi Therapeutics?
Trevi Therapeutics all-time high annual total debt is $14.63 M
What is Trevi Therapeutics annual total debt year-on-year change?
Over the past year, TRVI annual total debt has changed by -$7.84 M (-85.42%)
What is Trevi Therapeutics quarterly total debt?
The current quarterly total debt of TRVI is $1.11 M
What is the all time high quarterly total debt for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly total debt is $14.63 M
What is Trevi Therapeutics quarterly total debt year-on-year change?
Over the past year, TRVI quarterly total debt has changed by -$225.00 K (-16.82%)